For instance, DNMT inhibitors combined with BET inhibitors or immune checkpoint inhibitors have demonstrated synergistic anti-leukemic effects, enhancing AML cell sensitivity to apoptotic signals while reducing resistance development (Du et al., 2021). This evidence concerns the gene DNER and acute myeloid leukemia.